Microbiota experts discuss the importance of gut microbiota and probiotics

Watch videos from Dr Gianluca Ianiro and Dr Francisco Guarner where they discuss the role that microbiota plays in gut functioning and how important it is to maintain balance of the microbiota composition and diversity.

 

Dr. Gianluca laniro explains the importance of preserving gut microbiota and preventing the side effects of antibiotics.

Dr. Gianluca laniro, an Internal Medicine Specialist and Gastroenterologist at Fondazione Policlinico of University Agostino Gemelli, Rome, Italy, discusses the influence that gut microbiota have on our body.

He discusses how factors such as type of birth (vaginal or caesarean), feeding (breast or bottle-fed), life events such as physical stress (car accident), chemical stress (antibiotics), and infection stress (infectious diseases) shape microbiota composition and diversity. Dr Ianiro also highlights how influential the gut microbiota are on several important functions in the human body.

Finally, Dr Ianiro discusses what happens when there is a gut microbiota imbalance that leads to dysbiosis, and how it can have life-long effects. He also explains how balance can be restored, for example by taking probiotics such as the yeast probiotic Saccharomyces boulardii.

Dr. Francisco Guarner explains why a probiotic yeast is the need of the hour.

Dr. Francisco Guarner is a Consultant Gastroenterologist at University Hospital Vall D’hebron, Barcelona, Spain. In this video Dr Guarner tells us about the symbiosis between microbiota and human body.

Dr Guarner discusses the consequences of when the symbiotic relationship is disrupted, including its association with disease.

as well as the criteria for choosing a probiotic. Of particular note, he stresses how yeast probiotics have certain advantages over bacterial probiotics, including the fact that they are not susceptible to antibiotics. Dr Guarner highlights that this is important as human microbiota has changed a lot in the past 50 years due to the use of antibiotics, and that it is high time we use an adequate probiotic along with antibiotics as a therapy.

Watch videos from Professor Lynne McFarland and Dr Henry Cohen where they discuss the yeast probiotic Saccharomyces boulardii strain CNCM I-745 and the role it plays in maintaining microbiota balance and gastrointestinal health.

Professor Lynne McFarland, Associate Professor at the University of Washington, USA, discusses the probiotic Saccharomyces boulardii strain CNCM I-745, a non-pathogenic yeast. She highlights the unique history of this probiotic, including the fact that this strain has been studied in more than 100 clinical trials investigating its effectiveness in over 18 disease indications including acute diarrhea (infectious and non-infectious), antibiotic-associated diarrhea, gastrointestinal side effects associated with Helicobacter pylori eradication therapy, and Clostridium difficile disease.

In this video, Professor McFarland emphasizes that not all probiotics are effective, and that both strain specificity and disease specificity are important. Therefore,

Dr. Henry Cohen, Gastroenterologist at Facultad de medicina, Montevideo, Uruguay, explains in this video why Saccharomyces boulardii strain CNCM I-745 is unique. He highlights that

Dr. Cohen discusses how bacterial probiotics have an important risk to be inactivated by antibiotics. He also discusses recent studies that have shown that the use of Saccharomyces boulardii strain CNCM I-745 can reduce the risk of antibiotic-associated diarrhea, Clostridium difficile infection, and the reduction of gastrointestinal side effects from Helicobacter pylori eradication therapy. Finally, Dr Cohen talks about how S. boulardii CNCM I-745 has been included in the important guidelines by World Gastroenterology Organization (WGO) published in 2017 and the guideline by European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) that recommend the use of Saccharomyces boulardii CNCM I-745 to reduce the side effects of antibiotics.

Internal code : 20.58